Kelsey C Priest1, Honora Englander2, Dennis McCarty3. 1. School of Medicine, MD/PhD Program, Oregon Health & Science University, United States; School of Public Health, Oregon Health & Science University-Portland State University, United States. Electronic address: priest@ohsu.edu. 2. Division of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, United States; Section of Addiction Medicine, Division of General Internal Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, United States. 3. School of Public Health, Oregon Health & Science University-Portland State University, United States.
Abstract
BACKGROUND: Hospitalizations related to opioid use disorder (OUD) are increasing, necessitating an increase in the delivery of opioid agonist therapy (OAT) among hospitalized adults. The addiction consult service (ACS) is a promising organizational intervention to address this growing clinical need. Little is known about the barriers and facilitators of ACS development and operations. METHODS: We completed 17 semi-structured telephone interviews with board-certified or board-eligible addiction physicians across 16 U.S. acute care hospitals. Interviews explored contextual facilitators and barriers for ACS development and operations. We transcribed, coded, analyzed interviews, and derived final themes using a directed content analysis. RESULTS: We identified six themes that promoted or inhibited ACS development and operations: 1) stigma and discrimination; 2) internal (e.g., hospital administrators) and external stakeholders (e.g., State Medicaid programs); 3) addiction-informed institutions with addiction-related resources; 4) access to community-based treatment programs (e.g., local opioid treatment programs); 5) restrictive and misinterpreted OAT policies; and 6) service financing. The first theme, stigma and discrimination, is presented as a stand-alone-theme but permeates the five other themes as a broader meta-theme. CONCLUSIONS: As OUD-related hospitalizations increase, and the opioid-related overdose crisis continues, understanding the constraints related to the development and operations of ACSs are important preliminary steps for improving the care of patients hospitalized with OUD. Clinical champions, hospital leaders, and hospital societies could act, through practice and policy initiatives, to support ACS development and increase the delivery of evidence-based services (e.g., OAT) to patients hospitalized with OUD.
BACKGROUND: Hospitalizations related to opioid use disorder (OUD) are increasing, necessitating an increase in the delivery of opioid agonist therapy (OAT) among hospitalized adults. The addiction consult service (ACS) is a promising organizational intervention to address this growing clinical need. Little is known about the barriers and facilitators of ACS development and operations. METHODS: We completed 17 semi-structured telephone interviews with board-certified or board-eligible addiction physicians across 16 U.S. acute care hospitals. Interviews explored contextual facilitators and barriers for ACS development and operations. We transcribed, coded, analyzed interviews, and derived final themes using a directed content analysis. RESULTS: We identified six themes that promoted or inhibited ACS development and operations: 1) stigma and discrimination; 2) internal (e.g., hospital administrators) and external stakeholders (e.g., State Medicaid programs); 3) addiction-informed institutions with addiction-related resources; 4) access to community-based treatment programs (e.g., local opioid treatment programs); 5) restrictive and misinterpreted OAT policies; and 6) service financing. The first theme, stigma and discrimination, is presented as a stand-alone-theme but permeates the five other themes as a broader meta-theme. CONCLUSIONS: As OUD-related hospitalizations increase, and the opioid-related overdose crisis continues, understanding the constraints related to the development and operations of ACSs are important preliminary steps for improving the care of patients hospitalized with OUD. Clinical champions, hospital leaders, and hospital societies could act, through practice and policy initiatives, to support ACS development and increase the delivery of evidence-based services (e.g., OAT) to patients hospitalized with OUD.
Authors: Courtney D Nordeck; Christopher Welsh; Robert P Schwartz; Shannon Gwin Mitchell; Art Cohen; Kevin E O'Grady; Jan Gryczynski Journal: Drug Alcohol Depend Date: 2018-03-02 Impact factor: 4.492
Authors: Sarah E Wakeman; Joshua P Metlay; Yuchiao Chang; Grace E Herman; Nancy A Rigotti Journal: J Gen Intern Med Date: 2017-05-19 Impact factor: 5.128
Authors: Alexander C Tsai; Mathew V Kiang; Michael L Barnett; Leo Beletsky; Katherine M Keyes; Emma E McGinty; Laramie R Smith; Steffanie A Strathdee; Sarah E Wakeman; Atheendar S Venkataramani Journal: PLoS Med Date: 2019-11-26 Impact factor: 11.069
Authors: Leslie W Suen; Anil N Makam; Hannah R Snyder; Daniel Repplinger; Margot B Kushel; Marlene Martin; Oanh Kieu Nguyen Journal: J Gen Intern Med Date: 2021-09-13 Impact factor: 6.473
Authors: Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty Journal: J Gen Intern Med Date: 2020-04-14 Impact factor: 5.128
Authors: Susan L Calcaterra; Steve Lockhart; Catherine Callister; Kaitlyn Hoover; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473
Authors: Nichole Moore; Michael Kohut; Henry Stoddard; Debra Burris; Frank Chessa; Monica K Sikka; Daniel Solomon; Colleen M Kershaw; Ellen Eaton; Rebecca Hutchinson; Kathleen M Fairfield; Thomas J Stopka; Peter Friedmann; Kinna Thakarar Journal: Ther Adv Infect Dis Date: 2022-10-06